Understanding how sexual networks affect HIV testing and treatment in sub-Saharan Africa.
Official title: Sexual network structure and HIV testing and treatment in sub-Saharan Africa: understanding the implications for ending the HIV epidemic.
Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11009107 · Data updated 2026-11-12
This study looks at how people's connections and relationships affect HIV testing and treatment in sub-Saharan Africa, especially for those who might be overlooked, to find better ways to help everyone get the care they need.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project start | July 16, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $186,095 |
| NIH project number | 1K01MH135767-01A1 |
| Project ID | NIH-11009107 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals living in sub-Saharan Africa who are at risk of HIV or have not been tested for HIV.
✕Less likely to help
Patients who are already engaged in regular HIV testing and treatment may not receive additional benefits from this research.
What this research studies
This research investigates the impact of sexual network structures on HIV testing and treatment in sub-Saharan Africa, where the HIV epidemic remains a significant challenge. By analyzing how individuals are connected within these networks, the study aims to identify disparities in testing and treatment engagement, particularly among marginalized populations. The approach includes network analyses, simulations, and community interviews to gather comprehensive data. The findings will help inform strategies to improve HIV prevention and treatment efforts at the population level.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV testing and treatment strategies, ultimately reducing transmission rates in affected communities.
How similar studies have gone: Previous research has shown that targeted testing strategies can be effective, but this specific approach examining sexual network structures is relatively novel.
Where this research is happening
-
Pennsylvania State Univ Hershey Med Ctr
Hershey, United States Active
Researchers
- Principal investigator: Risher, Kathryn — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Risher, Kathryn
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Understanding the STIM/Orai Calcium Signaling Pathway in Cancer
Researchers are studying how STIM and Orai proteins control calcium signals inside cells and how this affects cancer-related growth and remodeling, with hopes to find ways to influence these signals for better treatments.
-
Understanding how some Amish communities maintain high birth rates in modern times
A project will build a large, time-sensitive dataset to understand why Amish families keep having many children, even as broader society has much lower birth rates.
-
Scoliosis and neurosurgical factors in myelomeningocele: a clinic registry study
This project uses registry data from Penn State’s Spina Bifida Clinic to understand how brain and spine-related issues influence when and why scoliosis surgery is needed in people with myelomeningocele.
-
Understanding how damaged stomach cells revert to a repair state to prevent cancer
Researchers are studying how certain stomach cells re-enter the cell cycle to aid tissue repair, and how this process might lead to metaplasia or cancer if it goes wrong.
-
Aging, cell aging, and how MCPyV causes Merkel cell carcinoma
Aging and aging-related changes in skin cells may help a common virus (MCPyV) persist and potentially lead to a rare skin cancer in people with weaker immune systems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.